Sanofi (NASDAQ:SNY) Sees Strong Trading Volume

Sanofi (NASDAQ:SNY) shares saw strong trading volume on Thursday . 1,731,194 shares traded hands during mid-day trading, a decline of 14% from the previous session’s volume of 2,013,341 shares.The stock last traded at $48.97 and had previously closed at $50.03.

Analysts Set New Price Targets

SNY has been the subject of a number of recent analyst reports. TheStreet cut Sanofi from a “b” rating to a “c” rating in a research report on Friday, February 9th. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Morgan Stanley began coverage on shares of Sanofi in a research note on Tuesday, January 23rd. They set an “equal weight” rating and a $55.00 target price for the company. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $55.00.

Sanofi Price Performance

The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The stock has a market capitalization of $124.61 billion, a price-to-earnings ratio of 24.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock has a 50 day moving average price of $47.86 and a 200-day moving average price of $48.26.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, February 1st. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.05). Sanofi had a net margin of 10.52% and a return on equity of 19.69%. The firm had revenue of $11.76 billion during the quarter, compared to analysts’ expectations of $13.02 billion. On average, analysts forecast that Sanofi will post 4.12 earnings per share for the current year.

Sanofi Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, June 6th. Stockholders of record on Friday, May 10th will be paid a $1.478 dividend. This is an increase from Sanofi’s previous annual dividend of $1.38. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. Sanofi’s dividend payout ratio (DPR) is currently 69.35%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Clearbridge Investments LLC boosted its position in shares of Sanofi by 8.4% during the 3rd quarter. Clearbridge Investments LLC now owns 184,630 shares of the company’s stock valued at $9,904,000 after acquiring an additional 14,362 shares during the last quarter. Dynamic Advisor Solutions LLC purchased a new position in Sanofi during the fourth quarter worth about $2,104,000. Soros Fund Management LLC acquired a new position in Sanofi in the 3rd quarter valued at about $11,533,000. International Assets Investment Management LLC purchased a new stake in shares of Sanofi in the 4th quarter valued at approximately $4,704,000. Finally, Clear Street Markets LLC increased its holdings in shares of Sanofi by 352.8% during the 3rd quarter. Clear Street Markets LLC now owns 130,183 shares of the company’s stock worth $6,983,000 after buying an additional 101,430 shares during the last quarter. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.